Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Cardiovasc Pharmacol ; 54(5): 378-384, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19568180

RESUMEN

Large controlled trials have shown that intake of fish oil (marine n-3 fatty acids, eicosapentaenoic acid, and docosahexaenoic acid), whether from dietary sources or fish oil supplements, may exhibit beneficial effects on total and cardiovascular disease mortality. Stabilization of cell membranes and suppression of cardiac arrhythmias have been identified as possible mechanisms. Moreover, n-3 fatty acids have anti-inflammatory effects, reduce blood pressure, and may also be antiatherogenic. Finally, high doses of n-3 fatty acids can lower elevated serum triglyceride levels. The n-3 index (erythrocyte eicosapentaenoic acid plus docosahexaenoic acid) may be considered as a potential risk marker for coronary heart disease mortality, especially sudden cardiac death. The balance of n-6 to n-3 fatty acids is an important determinant in decreasing the risk for coronary heart disease, both in the primary and in the secondary prevention of coronary heart disease. Patients with known coronary heart disease should be recommended to consume n-3 fatty acid supplements at 1 g per day, without raising concerns for interactions with other medications or side effects. On the other hand, fish in the diet (preferably oily fish, 1-2 meals/week) should be considered as part of a healthy diet low in saturated fat.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Aceites de Pescado/administración & dosificación , Animales , Presión Sanguínea/efectos de los fármacos , Enfermedades Cardiovasculares/metabolismo , Grasas de la Dieta/administración & dosificación , Suplementos Dietéticos , Aceites de Pescado/química , Aceites de Pescado/uso terapéutico , Peces/metabolismo , Humanos
2.
Am Heart J ; 155(1): 175-81, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18082510

RESUMEN

BACKGROUND: Moderate alcohol drinking and marine omega-3 fatty acids (omega3) have both been associated with low mortality from coronary heart disease (CHD). However, there is little data evaluating the interactions of wine ethanol drinking with omega3 in CHD patients. METHODS: The relationships between wine drinking and marine omega3 were evaluated in a cross-sectional study in patients with CHD participating in a randomized trial testing the effect of a high alpha-linolenic acid (ALA, the main plant omega3) diet. Daily ethanol intake was calculated as energy and expressed as a percentage of total energy. Plant and marine omega3 in the diet were carefully evaluated in each patient in both groups. RESULTS: Patients were classified according to their habitual consumption of ethanol. Patients in the "high ALA group" and controls ("low ALA group") were analyzed separately. Within each group, there was a progressive increase in marine omega3 levels with increased alcohol intake, with a level of eicosapentanoic acid (EPA) that increased by 50% (P < .005) and 37% (P < .05) in the low and high ALA groups, respectively. After controlling for potential confounders (including dietary EPA) in a multivariate linear model, the association between wine ethanol and EPA remained significant in the low (P < .001) and high (P < .05) ALA groups. CONCLUSION: In these patients with CHD, moderate wine drinking was associated with higher marine omega3 concentrations than no alcohol use. Although the data have to be confirmed in large groups, this effect of wine comparable to that of fish may partly explain the protective effects of wine drinking against CHD.


Asunto(s)
Enfermedad Coronaria/terapia , Etanol/administración & dosificación , Ácidos Grasos Omega-3/administración & dosificación , Ácidos Grasos Omega-3/sangre , Interacciones Alimento-Droga , Anciano , Consumo de Bebidas Alcohólicas , Enfermedad Coronaria/mortalidad , Enfermedad Coronaria/prevención & control , Estudios Transversales , Femenino , Aceites de Pescado/administración & dosificación , Aceites de Pescado/sangre , Estudios de Seguimiento , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Probabilidad , Valores de Referencia , Tasa de Supervivencia , Resultado del Tratamiento
3.
J Nutr ; 138(4): 747-52, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18356330

RESUMEN

Consumption of flavonoid-rich foods and beverages is thought to reduce the risk of cardiovascular diseases. Whereas the biological activities of flavonoids have been characterized in vitro, there are no clear experimental data demonstrating that chronic dietary intake and intestinal absorption of flavonoids actually protects the heart against ischemia-reperfusion injury. We tested whether long-term consumption of specific flavonoids (anthocyanins) included in normal food could render the heart of rats more resistant to myocardial infarction. Maize kernels that differed specifically in their accumulation of anthocyanins were used to prepare rodent food in which anthocyanins were either present or absent. Male Wistar rats were fed the anthocyanin-rich (ACN-rich) or the anthocyanin-free (ACN-free) diet for a period of 8 wk. Anthocyanins were significantly absorbed and detected in the blood and urine of only rats fed the ACN-rich diet. In Langendorff preparations, the hearts of rats fed the ACN-rich diet were more resistant to regional ischemia and reperfusion insult. Moreover, on an in vivo model of coronary occlusion and reperfusion, infarct size was reduced in rats that ate the ACN-rich diet than in those that consumed the ACN-free diet (P < 0.01). Cardioprotection was associated with increased myocardial glutathione levels, suggesting that dietary anthocyanins might modulate cardiac antioxidant defenses. Our findings suggest important potential health benefits of foods rich in anthocyanins and emphasize the need to develop anthocyanin-rich functional foods with protective activities for promoting human health.


Asunto(s)
Antocianinas/administración & dosificación , Antocianinas/farmacología , Corazón/efectos de los fármacos , Daño por Reperfusión Miocárdica/prevención & control , Animales , Antocianinas/análisis , Antocianinas/genética , Esquema de Medicación , Regulación de la Expresión Génica de las Plantas , Masculino , Miocardio/metabolismo , Ratas , Ratas Wistar , Zea mays/química , Zea mays/genética , Zea mays/metabolismo
4.
Br J Nutr ; 100(6): 1237-44, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18445308

RESUMEN

Moderate ethanol drinking (ED) and n-3 fatty acids have both been associated with low cardiac mortality. However, there are few data evaluating the interactions of ED with n-3. We recently reported that moderate ED results in increased n-3 in cardiac patients. The main aim of the present study was, through a well-controlled experimental model, to confirm that chronic ED actually results in increased n-3. Secondary aims were to examine the effects of chronic ED on cardiac mitochondria, cardiac function and experimental myocardial infarction. We studied the fatty acid profiles of plasma, cell membranes and cardiac mitochondria phospholipids in a rat model of chronic ED. In plasma and cell membranes, ED actually resulted in higher n-3 (P = 0.005). In mitochondria phospholipids of ED rats, n-3 were also increased (P < 0.05) but quite modestly. Cardiac mitochondrial function and left ventricular function were not significantly different in ED and control rats, while infarct size after 30 min ischaemia and reperfusion was smaller (P < 0.0001) in ED rats. This is the first animal study confirming interaction of alcohol drinking with n-3. We found no harmful effect of chronic ED on the heart in that model but a significant cardioprotection. Further studies are warranted to investigate the mechanisms by which moderate ED alters the metabolism of n-3 and whether n-3 are the mediators of the ED-induced cardioprotection.


Asunto(s)
Consumo de Bebidas Alcohólicas/sangre , Ácidos Grasos Omega-3/sangre , Animales , Membrana Celular/metabolismo , Modelos Animales de Enfermedad , Etanol/administración & dosificación , Etanol/farmacología , Ácidos Grasos/sangre , Lípidos/sangre , Masculino , Mitocondrias Cardíacas/efectos de los fármacos , Mitocondrias Cardíacas/metabolismo , Mitocondrias Cardíacas/fisiología , Daño por Reperfusión Miocárdica/patología , Daño por Reperfusión Miocárdica/prevención & control , Fosfolípidos/metabolismo , Ratas , Ratas Wistar , Función Ventricular Izquierda/efectos de los fármacos
5.
Cardiovasc Drugs Ther ; 22(6): 437-42, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18690528

RESUMEN

BACKGROUND: Reperfusion of the ischemic myocardium is associated with increased inflammatory processes that can exert deleterious effects and therefore contribute to cardiac dysfunction. The aim of the present study was to verify whether the administration of sTNFR-Fc, a scavenger of the pro-inflammatory cytokine TNF-alpha, at the time of reperfusion would protect against myocardial infarction and reduce the severity of early mechanical dysfunction. METHODS: Male Wistar rats were subjected to 60 min coronary occlusion followed by reperfusion. A bolus of sTNFR-Fc (10 microg/kg, i.v.) (MI + sTNFR-Fc group) or a placebo (MI group) was injected prior to reperfusion. Cardiac geometry was assessed by echocardiography 1, 3 and 7 days after reperfusion. Eight days after reperfusion, left ventricular (LV) function was evaluated under basal conditions and during an experimental challenge of volume overload. Finally, infarct size was measured after euthanasia. RESULTS: sTNFR-Fc administration markedly reduced infarct size (P < 0.01) and decreased LV dilation as assessed by the echocardiographic measurement of the LV end diastolic area, 7 days post-MI (P < 0.01). Moreover, LV end-diastolic pressure was significantly preserved by sTNFR-Fc 1 week after myocardial infarction, under basal conditions (P < 0.05) as well as during cardiac overload (P < 0.05). CONCLUSION: A single administration of sTNFR-Fc at the time of reperfusion after myocardial infarction is able to limit infarct size and to reduce early LV diastolic dysfunction in rats. These findings suggest that intravenous neutralization of TNF-alpha during surgical cardiac reperfusion might improve the outcome of myocardial infarction in humans.


Asunto(s)
Inmunoglobulina G/uso terapéutico , Inyecciones Intravenosas/métodos , Infarto del Miocardio/tratamiento farmacológico , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Proteínas Recombinantes/uso terapéutico , Animales , Interpretación Estadística de Datos , Modelos Animales de Enfermedad , Ecocardiografía/métodos , Etanercept , Azul de Evans , Predicción , Hemodinámica/efectos de los fármacos , Humanos , Inmunoglobulina G/administración & dosificación , Inmunoglobulina G/farmacología , Masculino , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/patología , Daño por Reperfusión Miocárdica/patología , Ratas , Ratas Wistar , Receptores del Factor de Necrosis Tumoral/administración & dosificación , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/farmacología , Coloración y Etiquetado/métodos , Factores de Tiempo , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismo , Disfunción Ventricular Izquierda/tratamiento farmacológico , Disfunción Ventricular Izquierda/fisiopatología
6.
Antioxid Redox Signal ; 9(6): 757-63, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17511592

RESUMEN

Myocardial infarction induces contractile dysfunction and remodeling that can lead to heart failure. Nitric oxide has been proposed as one of the major actors of this pathophysiologic process. We note that N (G)-nitro-L-arginine methyl ester (L-NAME) administration from day 2 to day 7 after myocardial infarction in rats improves stroke volume, preserves cardiac compliance, and reduces infarct expansion. Our observations lead to the hypothesis that the mechanisms by which cytokines contribute to myocardial remodeling and dysfunction in the days after infarction might involve *NO signalling pathways.


Asunto(s)
Cardiopatías/metabolismo , Cardiopatías/patología , Óxido Nítrico/metabolismo , Animales , Progresión de la Enfermedad , Masculino , Óxido Nítrico Sintasa de Tipo II/metabolismo , Ratas , Ratas Wistar
7.
Eur J Pharmacol ; 531(1-3): 187-93, 2006 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-16436276

RESUMEN

Calcium overload during hypoxia and reoxygenation exerts deleterious effects in endothelial and smooth muscle cells but potential effects of sodium-proton exchanger (NHE) inhibitors have never been investigated in both adult and senescent vessels. Isolated aortic rings from adult and senescent rats were submitted to hypoxia (50 min) or to hypoxia/reoxygenation (20/30 min) without or with cariporide (10(-6) M) and aortic vasoreactivity was recorded. After hypoxia, relaxation to acetylcholine was preserved in adult rings treated with cariporide (-22.3% vs. -9.3% of baseline value in control and treated groups respectively, P<0.05) but not in senescents. Cariporide treatment restored relaxation to acetylcholine after hypoxia-reoxygenation in adult rings (-32.04% vs. -0.03% of baseline value in control and treated groups respectively, P<0.01) and to a lesser extent, in senescent rings (-30.8% vs. -24.4% of baseline value in control and treated groups respectively, P<0.01). These results suggested that hypoxia induced lower acidosis and/or involved other mechanisms of proton extrusion than NHE in senescent aorta. Improvement of endothelial function with cariporide after reoxygenation in senescent aorta, but in a lesser extent than in adult aorta, suggests a lower role of NHE in pH regulation and subsequent calcium overload during aging.


Asunto(s)
Guanidinas/farmacología , Hipoxia/fisiopatología , Oxígeno/farmacología , Sulfonas/farmacología , Vasodilatación/efectos de los fármacos , Acetilcolina/farmacología , Factores de Edad , Animales , Aorta Torácica/efectos de los fármacos , Aorta Torácica/fisiología , Presión Sanguínea/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Técnicas In Vitro , Masculino , Nitroprusiato/farmacología , Fenilefrina/farmacología , Ratas , Ratas Wistar , Intercambiadores de Sodio-Hidrógeno/antagonistas & inhibidores , Factores de Tiempo , Vasoconstrictores/farmacología , Vasodilatadores/farmacología
8.
Circulation ; 106(12): 1465-9, 2002 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-12234949

RESUMEN

BACKGROUND: Scientific data on the clinical impact of moderate alcohol consumption after a recent acute myocardial infarction (AMI) are limited, and the specific effect of wine ethanol has not been studied. METHODS AND RESULTS: In survivors of a recent AMI, we analyzed the association between ethanol intake and the risk of recurrence. The patients were classified according to the amount of ethanol that they consumed regularly during follow-up. Major prognostic factors, including the severity of the prior AMI and drug treatment, were recorded and included in the analyses. Only patients with at least 2 reliable assessments of drinking (and dietary) habits were included (n=437). The average ethanol intake was 7.6% of the total energy intake, wherein wine ethanol represented 92% of the total. Among these patients, 104 cardiovascular complications occurred during a mean follow-up period of 4 years. In comparison with abstainers, the adjusted risk of complications was reduced by 59% (95% confidence interval: 17 to 80) in patients whose average ethanol intake was 7.7% of the total energy intake (about 2 drinks/day), and by 52% (95% confidence interval: 4 to 76) in those whose average ethanol intake was of 16% of energy (about 4 drinks/day). CONCLUSION: Whereas moderate wine drinking was associated with a significant reduction in the risk of complications in this homogenous population of coronary heart disease patients, further studies are required to confirm the data, define the clinical and biological profile of the patients who would most benefit from wine drinking after recent AMI, and examine whether the relations found are due to ethanol or other wine ingredients.


Asunto(s)
Enfermedades Cardiovasculares/etiología , Infarto del Miocardio/complicaciones , Vino/efectos adversos , Grasas de la Dieta , Etanol/efectos adversos , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/terapia , Pronóstico , Recurrencia , Factores de Riesgo , Sobrevivientes
9.
FASEB J ; 17(14): 2133-5, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12958158

RESUMEN

Heme oxygenase-1 (HO-1)-dependent carbon monoxide (CO) production related to reperfusion-induced ventricular fibrillation (VF) was studied in HO-1 wild-type (+/+), heterozygous (+/-), and homozygous (-/-) isolated ischemic/reperfused mouse heart. In HO-1 homozygous myocardium, under aerobic conditions, HO-1 enzyme activity, HO-1 mRNA, and protein expression were not detected in comparison with aerobically perfused wild-type and heterozygous myocardium. In wild-type, HO-1 hetero- and homozygous hearts subjected to 20 min ischemia followed by 2 h of reperfusion, the expression of HO-1 mRNA, protein, and HO-1 enzyme activity was detected in various degrees. A reduction in the expression of HO-1 mRNA, protein, and enzyme activity in fibrillated wild-type and heterozygous myocardium was observed. In reperfused/nonfibrillated wild-type and heterozygous hearts, a reduction in HO-1 mRNA, protein expression, and HO-1 enzyme activity was not observed, indicating that changes in HO-1 mRNA, protein, and enzyme activity could be related to the development of VF. These changes were reflected in the HO-1-related endogenous CO production measured by gas chromatography. In HO-1 knockout ischemic/reperfused myocardium, all hearts showed VF, and no detection in HO-1 mRNA, protein, and enzyme activity was observed. Thus, interventions that are able to increase endogenous CO may prevent the development of VF.


Asunto(s)
Monóxido de Carbono/metabolismo , Hemo Oxigenasa (Desciclizante)/metabolismo , Miocardio/enzimología , Animales , Hemo Oxigenasa (Desciclizante)/análisis , Hemo Oxigenasa (Desciclizante)/fisiología , Hemo-Oxigenasa 1 , Inmunohistoquímica , Proteínas de la Membrana , Ratones , Ratones Noqueados , Modelos Biológicos , Daño por Reperfusión Miocárdica/enzimología , Daño por Reperfusión Miocárdica/metabolismo , Miocardio/química , Miocardio/metabolismo , Técnicas de Cultivo de Órganos , ARN Mensajero/biosíntesis , Fibrilación Ventricular/enzimología , Fibrilación Ventricular/metabolismo
10.
J Trace Elem Med Biol ; 19(1): 43-7, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16240671

RESUMEN

Recent studies have demonstrated that electrical uncoupling at gap junctions during ischemia is associated with cardiac Connexin-43 (Cx43) dephosphorylation. Whether oxidative stress is involved in this phenomenon still remains unclear. In the present study, we examined the influence of selenium intake on reperfusion-induced Cx43 dephosphorylation. Male Wistar rats were fed a diet containing either 0.05 mg/kg (Low-Se, n = 13) or 1.5 mg/kg (High-Se, n = 11) selenium for 8 weeks. At the end of this diet, hearts were isolated and subjected to 10 min regional ischemia followed by 10 min reperfusion. The level of dephosphorylated Cx43 was determined in tissue samples from ischemic/reperfused and non-ischemic regions of the hearts. At the end of the experiemental diet, the activity of the antioxidant enzyme glutathione peroxidase (GSH-Px) was increased in high-Se hearts compared with low-Se hearts (+ 13%; p < 0.05). After ischemia/reperfusion, in low-Se hearts, Cx43 dephosphorylation appeared significantly increased in the left ventricle compared to the non-ischemic right ventricle (+ 149%; p < 0.05). The high-Se diet significantly reduced Cx43 dephosphorylation in the left ventricle (p < 0.05 vs. low-Se diet). In conclusion, our results suggest that oxidative stress may be involved in Cx43 dephosphorylation during myocardial ischemia/reperfusion, thereby contributing to arrhythmogenesis.


Asunto(s)
Conexina 43/metabolismo , Isquemia Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/metabolismo , Reperfusión Miocárdica , Miocardio/metabolismo , Selenio/metabolismo , Animales , Arritmias Cardíacas/metabolismo , Dieta , Uniones Comunicantes/metabolismo , Glutatión Peroxidasa/metabolismo , Técnicas In Vitro , Masculino , Estrés Oxidativo , Fosforilación , Distribución Aleatoria , Ratas , Ratas Wistar , Selenio/administración & dosificación
11.
Antioxid Redox Signal ; 5(1): 115-22, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12626123

RESUMEN

To date, the involvement of reactive oxygen species in ischemic preconditioning in vivo in rats is not clearly demonstrated. The aim of the present study was to determine whether N-(2-mercaptopropionyl)glycine (MPG), a cell-diffusible hydroxyl radical scavenger, and carnosine, a potent singlet oxygen quencher, could block protection afforded by a single cycle of ischemic preconditioning in vivo in the rat. An ESR study was first performed to validate in vitro the specific antioxidant properties of carnosine and MPG. In a second set of experiments, open-chest rats were subjected to 30 min of left coronary occlusion followed by 60 min of reperfusion. Preconditioning was elicited by 5 min of ischemia and 5 min of reperfusion. Neither MPG (1-h infusion, 20 mg/kg) nor carnosine injection (bolus, 25 micro mol/rat) affected infarct size. The infarct size-limiting effect of preconditioning was completely blunted by MPG, whereas carnosine did not alter the cardioprotection. It is concluded that free radicals and especially hydroxyl radicals could be involved in the adaptive mechanisms induced by a single cycle of preconditioning in vivo in rats.


Asunto(s)
Glicina/análogos & derivados , Precondicionamiento Isquémico Miocárdico , Especies Reactivas de Oxígeno , Animales , Carnosina/química , Relación Dosis-Respuesta a Droga , Espectroscopía de Resonancia por Spin del Electrón , Depuradores de Radicales Libres/farmacología , Glicina/farmacología , Hemodinámica , Histidina/química , Radical Hidroxilo , Masculino , Modelos Genéticos , Ratas , Ratas Wistar , Daño por Reperfusión , Compuestos de Sulfhidrilo/farmacología , Factores de Tiempo
12.
Antioxid Redox Signal ; 6(2): 431-8, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15025945

RESUMEN

It is now well established that oxidative stress resulting from reactive oxygen species (ROS) that are generated in cardiac myocytes subjected to ischemia/reperfusion plays a causative role in the development of heart failure and may contribute to promote cell death. During the last decade, several groups have reported that, in animal models of myocardial ischemia/reperfusion, certain nutrients, including ethanol and nonethanolic components of wine, may have a specific protective effect on the myocardium, independent of the classical risk factors implicated in vascular atherosclerosis and thrombosis. Mechanisms through which the consumption of alcoholic beverages protects against ischemia-induced cardiac injury are still unknown. One major open question is whether ethanol and nonethanolic components of wine are cardioprotective, at least in part, by interfering with the myocardial prooxidant/antioxidant balance. Important concepts, such as cardiac preconditioning, are now entering the field of nutrition, and recent experimental evidence suggests that ethanol and/or nonethanolic components of wine might exert preconditioning effects in animal models of myocardial ischemia/reperfusion. There is no doubt that such an observation, if confirmed in human subjects, might open new perspectives in the prevention and treatment of ischemic coronary heart disease.


Asunto(s)
Antioxidantes/metabolismo , Etanol/farmacología , Corazón/efectos de los fármacos , Oxidantes/metabolismo , Daño por Reperfusión/prevención & control , Vino , Animales , Humanos , Miocardio/metabolismo , Oxidación-Reducción , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo
13.
Antioxid Redox Signal ; 6(4): 792-6, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15242560

RESUMEN

Prospective epidemiological studies have shown that the incidence of numerous cardiovascular pathologies is correlated with body selenium status. However, it remains unclear whether selenium status also influences the outcome of myocardial infarction. The aim of the present study was to test whether dietary selenium intake affects myocardial necrosis induced by transient regional ischemia in vivo in rats. For this purpose, male Wistar rats received either a high-selenium (High-Se: 1.5 mg of Se/kg) or a low-selenium (Low-Se: 0.05 mg of Se/kg) diet for 10 weeks. Animals were subjected to 30 min of myocardial ischemia induced by coronary artery ligation followed by 60 min of reperfusion. Pre- and postischemic blood samples were collected for glutathione (GSH and GSSG) determination and for glutathione peroxidase (GSH-Px) assessment. Our results show that high-selenium intake reduces myocardial infarct size (High-Se: 25.16 +/- 1.19% versus Low-Se: 36.51 +/- 4.14%, p < 0.05), preserves postischemic GSH/GSSG ratio (High-Se: 1.37 +/- 0.37 versus Low-Se: 0.47 +/- 0.10, p < 0.05), increases plasma GSH-Px activity, and improves postischemic mean arterial pressure. In conclusion, preischemic body selenium status is a major determinant of the outcome of myocardial ischemia in vivo in rats probably because it influences the cellular redox status.


Asunto(s)
Infarto del Miocardio/patología , Isquemia Miocárdica/metabolismo , Selenio/sangre , Animales , Presión Sanguínea , Dieta , Glutatión/sangre , Glutatión Peroxidasa/sangre , Humanos , Masculino , Oxidación-Reducción , Distribución Aleatoria , Ratas , Ratas Wistar , Selenio/administración & dosificación
14.
Mech Ageing Dev ; 124(2): 229-35, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12633943

RESUMEN

Reactive oxygen species (ROS) are involved in the post-ischemic reperfusion syndrome of the myocardium. Moreover, ageing is associated with an increased cardiac sensitivity to both ischemia and reperfusion. The aim of the present study was to determine whether the lower tolerance of aged hearts to reperfusion could be due to an increased sensitivity to the ROS that are produced during the early phase of reperfusion. For this purpose isolated perfused hearts from adult (4 months) and aged (24 months) rats were perfused with a buffer containing 150 microM of hydrogen peroxide (H(2)O(2)) in presence or absence of deferoxamine mesylate (150 microM), an iron chelator. H(2)O(2) perfusion was continued until left ventricular developed pressure had decreased up to 20% of its initial value. Ageing led to a significant reduction of the duration of the H(2)O(2) perfusion required for inducing a 80% functional alteration. Although deferoxamine did not affect this parameter in adult rats, it significantly increased the duration of H(2)O(2)-perfusion in senescent hearts (control: 14.0+/-0.9 min vs. deferoxamine: 18.1+/-1.0, P<0.05). Similarly, ageing aggravated cardiac contracture induced by H(2)O(2)-perfusion. Again, deferoxamine, which had no effect on this parameter in young adult hearts, significantly reduced the contracture of senescent rat hearts. To conclude, our data clearly show that ageing is associated with an increased sensitivity of the myocardium to hydrogen peroxide, which is partly reversed by iron chelation. These results suggest that the iron-catalyzed Fenton reaction producing hydroxyl radicals might be greater in hearts from senescent rats than in hearts from young adults.


Asunto(s)
Envejecimiento/metabolismo , Peróxido de Hidrógeno/toxicidad , Miocardio/metabolismo , Miocitos Cardíacos/efectos de los fármacos , Oxidantes/toxicidad , Animales , Deferoxamina/farmacología , Radical Hidroxilo/metabolismo , Hierro/metabolismo , Quelantes del Hierro/farmacología , Masculino , Contracción Miocárdica/efectos de los fármacos , Miocardio/citología , Miocitos Cardíacos/metabolismo , Ratas , Ratas Wistar
15.
Mech Ageing Dev ; 123(4): 275-85, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11744040

RESUMEN

To determine the effects of prolonged hypoxia and hypoxia-reoxygenation in senescent blood vessels, isolated aortic rings from 4- and 24-month-old (mo) Wistar rats were submitted to prolonged hypoxia (50 min) or hypoxia/reoxygenation (20 min/30 min) and contractile function recorded. Phenylephrine-induced contraction and sodium nitroprusside- and acetylcholine-induced relaxations were measured after hypoxia or after hypoxia/reoxygenation. In 24 mo group, prolonged hypoxia increased (+83%, P<0.01) and prolonged initial hypoxic contraction, while hypoxic relaxation and delayed contraction were unchanged. Relaxation to acetylcholine was more reduced than in 4 mo group while contraction to phenylephrine and relaxation to sodium nitroprusside were similarly impaired. During reoxygenation, contraction was of same amplitude at both ages and the relaxation to acetylcholine was impaired but to a similar extent in both groups. In conclusion, hypoxic stress induces a greater endothelium-injury in senescent aorta, and increased transient hypoxic contraction, without aggravation of late hypoxic contraction. Aging does not exacerbate the impairment of aortic vasoreactivity after hypoxia-reoxygenation, especially endothelium-dependent relaxation, in sharp contrast to prolonged hypoxia. These age-related changes in vascular sensitivity to oxygen deprivation are different from those observed in coronary arteries, indicating that vasoreactivity during such pathological stress strongly depends on the type of vessel, especially during aging.


Asunto(s)
Envejecimiento/fisiología , Aorta/fisiopatología , Oxígeno/fisiología , Acetilcolina/farmacología , Animales , Aorta/efectos de los fármacos , Hipoxia , Masculino , Nitroprusiato/farmacología , Fenilefrina/farmacología , Ratas , Ratas Wistar , Vasoconstrictores/farmacología , Vasodilatadores/farmacología
16.
Invest Ophthalmol Vis Sci ; 45(10): 3727-32, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15452083

RESUMEN

PURPOSE: There is increasing evidence to show cytoprotective effects of various flavonoid-rich extracts and the tissue-protective capacity of flavonoid-rich extract of sour cherry is due to flavonoid components of seeds. Sour cherry seed flavonoids were evaluated for their contribution to postischemic recovery related to endogenous carbon monoxide (CO) production in rat retinas subjected to ischemia/reperfusion. METHODS: Rats were orally treated with selected doses of flavonoid-rich extract of sour cherry seeds for 2 weeks. Animals were anesthetized, and a suture was placed behind the globe including the central retinal artery. Next, retinas were subjected to 90 minutes of ischemia followed by 24 hours of reperfusion. After this procedure, heme oxygenase-1 (HO-1)-related protein expression and enzyme activity, HO-1-related endogenous CO production, and ionic imbalance including tissue Na(+), K(+), and Ca(2+) in untreated and treated ischemic/reperfused retinas were measured. RESULTS: Retinal ischemia/reperfusion resulted in a significant reduction (to 10%) in HO-1 protein expression, enzyme activity, and HO-1-related endogenous CO production in the retina. These changes were accompanied by increases in retinal Na(+) and Ca(2+) gains and loss of K(+). In rats treated with 10 and 30 mg/kg of sour cherry flavonoid-rich extract, after 24 hours of reperfusion, tissue Na(+) and Ca(2+) accumulation and K(+) loss were prevented in comparison with the drug-free control. CONCLUSIONS: Sour cherry seed flavonoid-rich extract showed a protective effect against reperfusion-induced injury through its ability to reduce the changes in concentrations of retinal ions through HO-1-related endogenous CO production in the ischemic/reperfused retina.


Asunto(s)
Monóxido de Carbono/metabolismo , Flavonoides/uso terapéutico , Hemo Oxigenasa (Desciclizante)/metabolismo , Fitoterapia , Daño por Reperfusión/prevención & control , Retina/efectos de los fármacos , Animales , Western Blotting , Calcio/metabolismo , Cromatografía de Gases , Hemo-Oxigenasa 1 , Extractos Vegetales/uso terapéutico , Potasio/metabolismo , Ratas , Daño por Reperfusión/metabolismo , Retina/metabolismo , Semillas/química , Sodio/metabolismo
17.
Curr Pharm Des ; 19(39): 6906-11, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23590153

RESUMEN

Metabolic disorders such as insulin resistance (IR) and dyslipidemia (DL) might contribute to the induction of diabetic cardiomyopathy (DCM). However, few relevant animal models are currently available for studying the time-course of DCM and evaluating experimental therapeutics. The present study proposes a rodent model of dietary-induced IR combined or not with DL in order to investigate the impact of chronic IR and DL on in vivo myocardial function. Male rats were fed a western-type diet (65% fat; 15% fructose; WD). DL was induced by combining the western diet with i.p. injections of a nonionic surface-active agent (P-407; 0.2 mg/kg, 3 times/wk; P-407). A chow diet was used as control. At 11 and 14 weeks, cardiac function was assessed by echocardiography. Fasting blood glucose increased in WD group while plasma lipids markedly accumulated in P-407 treated rats. Echocardiographic data showed no significant difference in cardiac geometry under basal conditions. Diastolic dysfunction was evidenced at 14 weeks by a significant decrease in E/A ratio in the P-407 group. Moreover, fractional shortening was significantly depressed under dobutamine stress in WD group at 14 weeks whereas systolic dysfunction appeared as early as 11 weeks and worsened at 14 weeks in P-407 animals. Finally, myocardial TNF-alpha tissue content increased in P-407 group. In conclusion, DL exacerbated cardiac lipotoxicity and functional complications associated with IR. This experimental model of combined IR and DL closely mimics the main clinical manifestations of DCM and might therefore constitute a useful tool for the evaluation of pharmacological treatments.


Asunto(s)
Dislipidemias/inducido químicamente , Corazón/fisiopatología , Resistencia a la Insulina , Animales , Ecocardiografía , Masculino , Ratas , Ratas Sprague-Dawley
18.
Mol Nutr Food Res ; 56(7): 1106-21, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22760983

RESUMEN

Selenium, a dietary trace mineral, essential for humans and animals, exerts its effects mainly through its incorporation into selenoproteins. Adequate selenium intake is needed to maximize the activity of selenoproteins, among which glutathione peroxidases have been shown to play a major role in cellular defense against oxidative stress initiated by excess reactive oxygen species. In humans, a low selenium status has been linked to increased risk of various diseases, including heart disease. The main objective of this review is to present current knowledge on the role of selenium in cardiac health. Experimental studies have shown that selenium may exert protective effects on cardiac tissue in animal models involving oxidative stress. Because of the narrow safety margin of this mineral, most interventional studies in humans have reported inconsistent findings. Major determinants of selenium status in humans are not well understood and several nondietary factors might be associated with reduced selenium status. In this review, we discuss recent studies regarding the role of selenoproteins in the cardiovascular system, the effect of dietary intake on selenium status, the impact of selenium status on cardiac health, and the cellular mechanisms that can be involved in the physiological and toxic effects of selenium.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Dieta , Selenio/uso terapéutico , Animales , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/metabolismo , Enfermedades Cardiovasculares/fisiopatología , Fenómenos Fisiológicos Cardiovasculares , Sistema Cardiovascular/metabolismo , Sistema Cardiovascular/fisiopatología , Diabetes Mellitus Tipo 2/etiología , Dieta/efectos adversos , Dislipidemias/etiología , Humanos , Estrés Oxidativo , Selenio/administración & dosificación , Selenio/efectos adversos , Selenio/deficiencia , Selenoproteínas/metabolismo
19.
Mol Nutr Food Res ; 55(4): 522-9, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21462319

RESUMEN

SCOPE: Post-infarct left ventricular dysfunction and cardiac remodeling are the primary causes of chronic heart failure in industrialized countries. In the present study, we examined the influence of dietary selenium intake on cardiac remodeling after reperfused myocardial infarction and explored one of the possible mechanisms. METHODS AND RESULTS: Rats were fed a diet containing either 0.05 mg/kg (Low-Se, group of rats receiving the low-selenium diet) or 1.50 mg/kg (group of rats receiving the high-selenium diet) selenium. At the end of the 5th week of the diet, rats were subjected to transient (1 h) coronary ligation followed by 8 days of reperfusion. Infarct size and cardiac passive compliance were increased in the Low-Se group compared with group of rats receiving the high-selenium diet. Similarly, indices of cardiac remodeling (thinning index and expansion index) were more altered in Low-Se hearts. These adverse effects of the Low-Se diet on cardiac remodeling were accompanied by an increase in cardiac TNF-α content, a decreased activity of antioxidant seleno-enzymes and an increase in connexin-43 dephosphorylation. CONCLUSION: Dietary selenium intake influences post-infarct cardiac remodeling even when provided within the range of physiological values. Our data suggest that the cardioprotective effect of selenium might be mediated by a reduced oxidative stress, a lower connexin-43 dephosphorylation, and a decreased TNF-α expression.


Asunto(s)
Conexina 43/metabolismo , Dieta , Daño por Reperfusión Miocárdica/metabolismo , Selenio/administración & dosificación , Factor de Necrosis Tumoral alfa/metabolismo , Remodelación Ventricular , Animales , Adaptabilidad , Enfermedades Carenciales/fisiopatología , Glutatión Peroxidasa/metabolismo , Ventrículos Cardíacos/química , Ventrículos Cardíacos/fisiopatología , Masculino , Proteínas Musculares/metabolismo , Daño por Reperfusión Miocárdica/sangre , Daño por Reperfusión Miocárdica/fisiopatología , Daño por Reperfusión Miocárdica/prevención & control , Miocardio/metabolismo , Miocardio/patología , Fosforilación , Distribución Aleatoria , Ratas , Ratas Wistar , Selenio/sangre , Selenio/deficiencia , Selenio/uso terapéutico , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Disfunción Ventricular Izquierda/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA